About | Free Trial

Last Update

2010-09-04T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Background Information

Employment History

Chief Executive Officer
ALBIOREX INTERNATIONAL HOLDING COMPANY LLC

President and Chief Operating Officer
Artes Medical , Inc.

Vice President of Sales and Marketing
Atrix Laboratories , Inc.

President and Chief Executive Officer
Unimed Pharmaceuticals , Inc.

Corporate Senior Vice President
Collagen

Web References (7 Total References)


Rees ...

www.albiorex.com [cached]

Rees Orland

...
Mr. Rees Orland. Upon completion of this Offering, Mr. Orland will become our Chief Executive Officer. Mr. Orland possesses over 25 years of experience in diverse U.S. and international private and public companies specializing in medical devices, prescription and non-prescription and consumer products. Most recently, Mr. Orland was President and COO of Artes Medical, Inc. a medical device company specializing in soft-tissue augmentation products. Mr. Orland led the company through the FDA approval process for treating facial wrinkles, pre-IDE approval for urinary stress/incontinence and led the business development and licensing effort. Prior to that, Mr. Orland was VP of Sales and Marketing at Atrix Laboratories, a drug-delivery company. He was also the President and CEO of Unimed Pharmaceuticals where he successfully turned the company around. Mr. Orland was Corporate Senior Vice President of Collagen Corporation (President of Collagen Biomedical and Collagen International divisions) where he created and introduced the first branded cosmetic service for injectable collagen and increased worldwide sales 30% in one year. Mr. Orland has also held positions with Helene Curtis, G.D. Searle, Miles Laboratories and Ogilvy & Mather.


Mr. Rees Orland, CEO ...

www.albiorex.com [cached]

Mr. Rees Orland, CEO rorland@albiorex.com


AMT Advanced Materials and Technologies : Main

www.amtbe.com [cached]

SAN DIEGO, Oct. 29 /PRNewswire/ -- Artes Medical, Inc. (Private), today announced that Rees M. Orland, President and COO, will present a Company update at the Medtech Insight's conference "Investments In Innovation": A Preview of Early Stage Medical Companies.

Mr. Orland's remarks will focus on progress in the development and testing of Artes Medical injectable microsphere formulations for the treatment of female stress urinary incontinence, GERD (heartburn) and for the treatment of dermal contour deficiencies (facial lines, wrinkles, and scars).
The company finished FDA-approved human clinical trials for its Artecoll(TM) product, one-of-a-kind permanent injectable filler for facial wrinkles and scars.Artecoll is sold outside the United States, mainly in Canada and Europe with over 200,000 patients estimated to have been treated since 1994.
Mr. Orland will also comment on the development of new applications for the Company's microsphere technology.
...
"The combination of population demographics and increased demand for improving one's appearance are rapidly expanding the markets for treatment of incontinence, heartburn and for dermal contour corrections," said Rees M. Orland, President and Chief Operating Officer of Artes Medical, Inc.
...
For additional information about Artes Medical, Inc., contact Rees M. Orland at 858-550-9999 or at http://www.artesmedical.com.


Today's News

www.prnewswire.com [cached]

SAN DIEGO , Oct. 29 /PRNewswire/ -- Artes Medical , Inc. , today announced that Rees M. Orland , President and COO , will present a Company update at the Medtech Insight's conference Investments In Innovation : A Preview of Early Stage Medical Companies.

Mr. Orland's remarks will focus on progress in the development and testing of Artes Medical injectable microsphere formulations for the treatment of female stress urinary incontinence , GERD and for the treatment of dermal contour deficiencies.
The company finished FDA-approved human clinical trials for its Artecoll ( ) product , one-of-a-kind permanent injectable filler for facial wrinkles and scars.Artecoll is sold outside the United States , mainly in Canada and Europe with over 200 , 000 patients estimated to have been treated since 1994.
Mr. Orland will also comment on the development of new applications for the Company's microsphere technology.
...
The combination of population demographics and increased demand for improving one's appearance are rapidly expanding the markets for treatment of incontinence , heartburn and for dermal contour corrections , said Rees M. Orland , President and Chief Operating Officer of Artes Medical , Inc..Physicians continue to seek safe , effective , and more durable treatments in response to patient demand.Our products provide new uses of well-known and broadly used biomaterials.We precisely design , engineer and purify these well known components to deliver long-term patient satisfaction..
The company's proprietary technology is based on precision designed and purified non-absorbable microspheres suspended in a viscous carrier matrix and placed into body tissue with fine gauge needles.Unlike collagen treatments , for example , that are repeated to maintain correction , Artes Medical products are designed to resist absorption by the body and maintain correction.
...
For additional information about Artes Medical , Inc. , contact Rees M. Orland at 858-550-9999 or at http : //www.artesmedical.com/.
Click here
SOURCE Artes Medical , Inc.Web Site : http : //www.artesmedical.com/


RTA - Entrepreneur Services - Seminars - Past Events

www.sdrta.org [cached]

Rees M. Orland, Artes Medical, Inc

Similar Profiles

Other People with this Name

Other people with the name Orland

Paul Orland
Tachyus

Diane Orland
Amsted Industries Incorporated

Cameron Orland
Remco Forwarding Limited

Simon Orland
MCS Leader Limited

Eric Orland
Eric Orland

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory